G2GBIO, Inc.
Founded in 2017 and listed on KOSDAQ in 2025, G2GBIO is a long-acting microsphere platform company with multiple licensing deals including one with Boehringer Ingelheim.
Price
Change
Market cap
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2023 (Phase 1 2)
- Phase 1GB-50012023-10-13
1 trial site
- Phase 1GB-60022023-09-18
1 trial site
R&D and key agreements
Source: DART corporate disclosureGB-7001 · 비만/당뇨 · 비임상 · A long-acting diabetes/obesity treatment designed for about one month of drug release using the company's microsphere platform.
GB-5001 · 치매 · 임상1상 완료(캐나다), 임상1상 완료(국내), 다회용량상승시험(MAD) 진행중(국내) · A one-month long-acting dementia treatment, licensed out to Korea Pharma Humedix in October 2022.
GB-6002 · 수술후통증조절 · 임상1상 완료(국내) · A postoperative pain treatment with drug release lasting three days or more.
GB-5112 · 치매 · 독성시험 완료
GB-5021 · 조현병 · 제형개발 완료
GB-6201/3 · 탈모 · 독성시험 완료
GB-7101/3 · 전립선암/성조숙증 · 제형개발 완료
GH-001 · B형간염 · 제형개발 진행중 · A three-month long-acting hepatitis B antiviral injectable, licensed out to Hanwha Pharma in April 2022.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition